tci Medicare Compliance & Reimbursement - 2004 Issue 37
Coverage: PET Coverage May Herald New Era In Clinical Trials
Subscribe or sign in to view the full article.
Article Overview
This article covers a recent CMS National Coverage Decision affecting Medicare payment for positron emission tomography in selected dementia-related scenarios and describes the possibility of a CMS-approved pragmatic clinical trial to generate evidence for broader future use. It is relevant to coders, compliance staff, clinicians, and health policy readers who follow Medicare coverage changes, diagnostic imaging policy, and federal clinical research initiatives. The article also provides background on pragmatic clinical trials and the collaboration among federal agencies involved in evidence development and coverage decisions.
Why This Topic Matters
Coverage policy for advanced imaging can affect access, reimbursement, and research requirements. Understanding the broader trial framework helps readers track how evidence generation may influence future Medicare decisions.
What You Will Learn
- How CMS is approaching Medicare coverage for PET in selected dementia-related circumstances
- Why evidence limitations can lead to restricted coverage or trial-based payment
- What pragmatic clinical trials are and why they matter to policy-focused research
- How federal agencies may collaborate on studies intended to inform coverage decisions
Who Should Read This
- Medical coders
- Coding auditors
- Compliance professionals
- Healthcare administrators
- Clinicians
- Health policy analysts
- Research coordinators
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com